O00255 (MEN1_HUMAN) Homo sapiens (Human)
Menin UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
49 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Human menin in complex with MLL peptide |
Heteromer Q03164; | 100 | 3×SO4; 2×1PE; | |||
| Human menin in complex with H3K79Me2 nucleosome |
Heteromer P02281; P06897; P62799; P84233; | 100.0 | ||||
| Crystal structure of human menin in complex with MLL1 and LEDGF |
Heteromer O75475; Q03164; | 100.0 | 1×CHD; 4×GGB; 1×0BR; 4×GLV; 4×SO4; | |||
| Crystal structure of human menin in complex with JunD |
Heteromer P17535; | 100.0 | ||||
| Crystal structure of human menin in complex with MLL1 |
Heteromer Q03164; | 100.0 | ||||
| Crystal structure of menin in complex with DS-1594b | homo-2-mer | 100.0 | 2×7IX; 2×UNX; 2×DMS; | |||
| Crystal structure of human menin in complex with a high-affinity macrocyclic peptidomimetics | homo-2-mer | 100.0 | ||||
| Inhibition of Human Menin by SNDX-5613 | homo-2-mer | 99.53 | 2×OQ4; 4×EDO; 1×MES; | |||
| Inhibition of Human Menin by SNDX-5613 | homo-2-mer | 99.76 | 2×OQ4; 4×MG; | |||
| Crystal Structure of Human Menin | monomer | 100.0 | ||||
| Structural insights into inhibition of the bivalent menin-MLL interaction by small molecules in leu… | monomer | 100 | 2×PEG; 1×PG4; 1×EPE; | |||
| Menin in complex with MI-352 | monomer | 100 | 3×PG4; 4×SO4; 4×DMS; 1×58P; 1×6E6; | |||
| Menin in complex with MI-389 | monomer | 100 | 1×58R; 3×DMS; 1×PG4; 5×SO4; 1×PEG; | |||
| Menin in complex with MI-503 | monomer | 100 | 1×3XW; 3×DMS; 1×PG4; 3×SO4; 1×EDO; 1×EPE; | |||
| Menin in complex with MI-326 | monomer | 100 | 1×59K; 5×DMS; 2×PG4; 1×PGE; 4×SO4; | |||
| Menin in complex with MI-3454 | monomer | 100 | 1×LMY; 4×DMS; 3×SO4; 1×PG4; | |||
| Human menin with bound inhibitor MI-2-2 | monomer | 100 | 1×0RT; 5×UNX; 1×EPE; 4×SO4; 2×PE4; 1×DMS; | |||
| Menin mutant - T349M in complex with Ziftomenib (KO-539) | monomer | 100 | 1×K5O; 2×PEG; 1×PG4; 1×EDO; 2×DMS; | |||
| Human menin with bound inhibitor MIV-3S | monomer | 100 | 1×SO4; 1×2VK; 1×PG4; 1×PGE; 2×PEG; 4×DMS; 1×TBF; | |||
| Human menin with bound inhibitor MIV-4 | monomer | 100 | 1×SO4; 1×2S9; 1×PG4; 3×PEG; 4×DMS; | |||
| Menin in complex with peptide inhibitor 25 | monomer | 100 | 4×DMS; 3×SO4; 1×PG4; | |||
| Human menin with bound inhibitor MIV-6R | monomer | 100 | 2×TBF; 1×2SF; 1×PG4; 3×SO4; 3×DMS; 1×PGA; | |||
| Human menin with bound inhibitor MI-2 | monomer | 100 | 1×0RO; 1×PEG; 5×UNX; 5×SO4; | |||
| Menin in complex with Ziftomenib (KO-539) | monomer | 100 | 1×K5O; 2×PEG; 3×SO4; 2×DMS; 2×PG4; 1×EDO; | |||
| Menin in complex with MI-2-3 | monomer | 100 | 1×59V; 4×DMS; 1×PGE; 1×PEG; 1×EPE; | |||
| Human menin with bound inhibitor MIV-5 | monomer | 100 | 1×2S7; 2×SO4; 1×PG4; 1×PEG; 3×DMS; 1×TBF; | |||
| Menin in complex with MI-574 | monomer | 100 | 3×DMS; 2×PG4; 4×SO4; 1×PEG; 1×58Q; | |||
| Menin in complex with MI-859 | monomer | 100 | 2×5A0; 4×SO4; 4×DMS; 1×PG4; 1×EDO; | |||
| Menin in complex with MI-1481 | monomer | 100 | 1×EEV; 3×DMS; 2×PG4; 3×SO4; 1×EDO; | |||
| Menin in complex with MI-336 | monomer | 100 | 1×58O; 3×DMS; 5×SO4; 3×PG4; | |||
| menin in complex with MI-136 | monomer | 100 | 4×SO4; 1×3XY; 1×PG4; 2×DMS; 1×EDO; | |||
| Menin in complex with MI-1482 | monomer | 100 | 1×FNV; 4×DMS; 2×PG4; 2×SO4; 1×EDO; | |||
| Human menin with bound inhibitor MIV-7 | monomer | 100 | 1×SO4; 1×2SE; 1×PGE; 2×PEG; 4×DMS; | |||
| menin in complex with MI-836 | monomer | 100 | 1×59X; 4×SO4; 4×DMS; 1×PG4; 1×PEG; | |||
| Menin in complex with MI-273 | monomer | 100 | 1×5A1; 4×DMS; 1×PG4; 1×PEG; 3×SO4; | |||
| Menin in complex with MI-333 | monomer | 100 | 1×59M; 4×DMS; 2×PGE; 1×EDO; 5×SO4; | |||
| Menin in complex with MI-319 | monomer | 100 | 1×59Q; 5×DMS; 2×PG4; 1×PEG; 4×SO4; | |||
| Human menin with bound inhibitor MIV-3R | monomer | 100 | 1×SO4; 1×2S6; 1×PG4; 2×PEG; 4×DMS; | |||
| Inhibition of Human Menin by VTP-50469 | monomer | 99.77 | 1×OP4; | |||
| Crystal structure of Human Menin in complex with BD-08 | monomer | 100 | 1×V6N; 3×EDO; 2×GOL; | |||
| Crystal structure of Human Menin in complex with Fragment 21 | monomer | 100 | 1×V6K; 7×EDO; 1×GOL; | |||
| Crystal structure of Human Menin in apo form | monomer | 100 | 2×EDO; | |||
| Crystal structure of Human Menin with fragment 16 | monomer | 100 | 1×V6Q; 2×GOL; 3×EDO; | |||
| Menin bound to inhibitor M-808 | monomer | 100.0 | 1×7MM; 5×7PR; | |||
| Menin bound to M-525 | monomer | 100.0 | 1×CJV; 4×7PR; | |||
| Menin bound to M-1121 | monomer | 100.0 | 1×YQV; 5×7PR; | |||
| Menin bound to M-89 | monomer | 100.0 | 1×HL7; 5×7PR; | |||
| Human Menin in complex with AJ21 | monomer | 100.0 | ||||
| Menin in complex with MI-853 | monomer | 100.0 | 1×DMS; 1×SO4; 1×EE7; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3u84.1.A | monomer | 0.77 | 99.27 | |||
2 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 1 | 3u84.1.A | monomer | 0.77 | 99.27 | |||
| Isoform 3 | 3u84.1.A | monomer | 0.78 | 99.22 | |||